{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:19:06Z","timestamp":1793272746708,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To investigate the usefulness of <jats:sup>18<\/jats:sup>F-FDG PET-CT for assessing large-vessel (LV) involvement in patients with suspected giant cell arteritis (GCA) and a negative temporal artery biopsy (TAB).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective review of our hospital databases was conducted to identify patients with suspected GCA and negative TAB who underwent an <jats:sup>18<\/jats:sup>F-FDG PET-CT in an attempt to confirm the diagnosis. The gold standard for GCA diagnosis was clinical confirmation after a follow-up period of at least 12\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of the 127 patients included in the study, 73 were diagnosed with GCA after a detailed review of their medical records.<\/jats:p>\n                <jats:p>Of the 73 patients finally diagnosed with GCA, <jats:sup>18<\/jats:sup>F-FDG PET-CT was considered positive in 61 cases (83.5%). Among the 54 patients without GCA, <jats:sup>18<\/jats:sup>F-FDG PET-CT was considered positive in only eight cases (14.8%), which included 1 case of Erdheim-Chester disease, 3 cases of IgG4-related disease, 1 case of sarcoidosis, and 3 cases of isolated aortitis.<\/jats:p>\n                <jats:p>Overall, the diagnostic performance of <jats:sup>18<\/jats:sup>F-FDG PET-CT for assessing LV involvement in patients finally diagnosed with GCA and negative TAB yielded a sensitivity of 83.5%, specificity of 85.1%, and a diagnostic accuracy of 84% with an area under the ROC curve of 0.844 (95% CI: 0.752 to 0.936). The sensitivity was 89% in occult systemic GCA and 100% in extracranial LV-GCA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study confirms the utility of <jats:sup>18<\/jats:sup>F-FDG PET-CT in patients presenting with suspected GCA and a negative TAB by demonstrating the presence of LV involvement across different subsets of the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-023-03254-w","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T05:00:49Z","timestamp":1704344449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Usefulness of 18F-FDG PET-CT for assessing large-vessel involvement in patients with suspected giant cell arteritis and negative temporal artery biopsy"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-8064","authenticated-orcid":false,"given":"Javier","family":"Narv\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Vidal-Montal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"S\u00e1nchez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Sabat\u00e9-Llobera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2358-6767","authenticated-orcid":false,"given":"Joan Miquel","family":"Nolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Cort\u00e9s-Romera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"3254_CR1","doi-asserted-by":"publisher","first-page":"1759720X2210963","DOI":"10.1177\/1759720X221096366","volume":"14","author":"M Bond","year":"2022","unstructured":"Bond M, Tomelleri A, Buttgereit F, Matteson EL, Dejaco C. Looking ahead: giant-cell arteritis in 10 years\u2019 time. Ther Adv Musculoskelet Dis. 2022;14:1759720X221096366.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"Suppl 124","key":"3254_CR2","first-page":"15","volume":"38","author":"MA Gonz\u00e1lez-Gay","year":"2020","unstructured":"Gonz\u00e1lez-Gay MA, Prieto-Pe\u00f1a D, Calder\u00f3n-Goercke M, Atienza-Mateo B, Casta\u00f1eda S. Giant cell arteritis: more than a cranial disease. Clin Exp Rheumatol. 2020;38(Suppl 124):15\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"3254_CR3","first-page":"506","volume":"56","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford). 2017;56:506\u201315.","journal-title":"Rheumatology (Oxford)"},{"key":"3254_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0049-0172(95)80010-7","volume":"24","author":"JT Lie","year":"1995","unstructured":"Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum. 1995;24:422\u201331.","journal-title":"Semin Arthritis Rheum"},{"issue":"suppl_2","key":"3254_CR5","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1093\/rheumatology\/kex424","volume":"57","author":"MJ Koster","year":"2018","unstructured":"Koster MJ, Matteson EL, Warrington KJ. Large-vessel giant cell arteritis: diagnosis, monitoring and management. Rheumatology (Oxford). 2018;57(suppl_2):ii32\u201342.","journal-title":"Rheumatology (Oxford)"},{"key":"3254_CR6","doi-asserted-by":"publisher","first-page":"105558","DOI":"10.1016\/j.jbspin.2023.105558","volume":"90","author":"SA Lyne","year":"2023","unstructured":"Lyne SA, Ruediger C, Lester S, Kaur G, Stamp L, Shanahan EM, et al. Clinical phenotype and complications of large vessel giant cell arteritis: a systematic review and meta-analysis. Joint Bone Spine. 2023;90:105558.","journal-title":"Joint Bone Spine"},{"key":"3254_CR7","doi-asserted-by":"publisher","first-page":"152017","DOI":"10.1016\/j.semarthrit.2022.152017","volume":"55","author":"AK Hemmig","year":"2022","unstructured":"Hemmig AK, Gozzoli D, Werlen L, Ewald H, Aschwanden M, Blockmans D, et al. Subclinical giant cell arteritis in new onset polymyalgia rheumatic. A systematic review and meta-analysis of individual patient data. Semin Arthritis Rheum. 2022;55:152017.","journal-title":"Semin Arthritis Rheum"},{"key":"3254_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.semarthrit.2015.06.009","volume":"45","author":"J Narv\u00e1ez","year":"2015","unstructured":"Narv\u00e1ez J, Estrada P, L\u00f3pez-Vives L, Ricse M, Zacar\u00edas A, Heredia S, et al. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica. Semin Arthritis Rheum. 2015;45:328\u201333.","journal-title":"Semin Arthritis Rheum"},{"key":"3254_CR9","doi-asserted-by":"publisher","unstructured":"Tomelleri A, van der Geest KSM, Khurshid MA, Sebastian A, Coath F, Robbins D, et al. Disease stratification in GCA and PMR: state of the art and future perspectives. Nat Rev Rheumatol. 2023. https:\/\/doi.org\/10.1038\/s41584-023-00976-8. Online ahead of print.","DOI":"10.1038\/s41584-023-00976-8"},{"key":"3254_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","volume":"79","author":"B Hellmich","year":"2020","unstructured":"Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79:19\u201330.","journal-title":"Ann Rheum Dis"},{"key":"3254_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","volume":"77","author":"C Dejaco","year":"2018","unstructured":"Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636\u201343.","journal-title":"Ann Rheum Dis"},{"key":"3254_CR12","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/art.41774","volume":"73","author":"M Maz","year":"2021","unstructured":"Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol. 2021;73:1349\u201365.","journal-title":"Arthritis Rheumatol"},{"key":"3254_CR13","doi-asserted-by":"publisher","unstructured":"Dejaco C, Ramiro S, Bond M, Bosch P, Ponte C, Mackie SL, et al. EULAR recommendations for the use of imaging in LV vasculitis in clinical practice: 2023 update Ann Rheum Dis 2023:ard-2023\u2013224543. https:\/\/doi.org\/10.1136\/ard-2023-224543. Online ahead of print.","DOI":"10.1136\/ard-2023-224543"},{"key":"3254_CR14","doi-asserted-by":"crossref","unstructured":"Slart RHJA; Writing group; Reviewer group; Members of EANM Cardiovascular; Members of EANM Infection & Inflammation; Members of Committees, SNMMI Cardiovascular; Members of Council, PET Interest Group; Members of ASNC; EANM Committee Coordinator. FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging 2018; 45:1250\u201369.","DOI":"10.1007\/s00259-018-3973-8"},{"key":"3254_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semarthrit.2019.07.008","volume":"50","author":"KA Quinn","year":"2020","unstructured":"Quinn KA, Rosenblum JS, Rimland CA, Gribbons KB, Ahlman MA, Grayson PC. Imaging acquisition technique influences interpretation of positron emission tomography vascular activity in large-vessel vasculitis. Semin Arthritis Rheum. 2020;50:71\u20136.","journal-title":"Semin Arthritis Rheum"},{"key":"3254_CR16","doi-asserted-by":"publisher","first-page":"914692","DOI":"10.1155\/2015\/914692","volume":"2015","author":"KD Lensen","year":"2015","unstructured":"Lensen KD, Comans EF, Voskuyl AE, van der Laken CJ, Brouwer E, Zwijnenburg AT, et al. Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET\/CT. Biomed Res Int. 2015;2015:914692.","journal-title":"Biomed Res Int"},{"key":"3254_CR17","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1097\/MD.0000000000000622","volume":"94","author":"M Soussan","year":"2015","unstructured":"Soussan M, Nicolas P, Schramm C, Katsahian S, Pop G, Fain O, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore). 2015;94:e622.","journal-title":"Medicine (Baltimore)"},{"key":"3254_CR18","doi-asserted-by":"publisher","first-page":"152183","DOI":"10.1016\/j.semarthrit.2023.152183","volume":"60","author":"J Narv\u00e1ez","year":"2023","unstructured":"Narv\u00e1ez J, Estrada P, Vidal-Montal P, S\u00e1nchez-Rodr\u00edguez I, Sabat\u00e9-Llobera A, Nolla JM, et al. impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis. Semin Arthritis Rheum. 2023;60:152183.","journal-title":"Semin Arthritis Rheum"},{"key":"3254_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40336-021-00445-w","volume":"9","author":"M Casali","year":"2021","unstructured":"Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, et al. State of the art of 18F-FDG PET\/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging. 2021;9:299\u2013339.","journal-title":"Clin Transl Imaging"},{"key":"3254_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.rdc.2022.03.006","volume":"48","author":"TA Kermani","year":"2022","unstructured":"Kermani TA, Byram K. Isolated aortitis: workup and management. Rheum Dis Clin North Am. 2022;48:705\u201324.","journal-title":"Rheum Dis Clin North Am"},{"key":"3254_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semarthrit.2006.12.005","volume":"37","author":"J Narv\u00e1ez","year":"2007","unstructured":"Narv\u00e1ez J, Bernad B, Roig-Vilaseca D, Garc\u00eda-G\u00f3mez C, G\u00f3mez-Vaquero C, Juanola X, et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum. 2007;37:13\u20139.","journal-title":"Semin Arthritis Rheum"},{"key":"3254_CR22","doi-asserted-by":"publisher","first-page":"1055178","DOI":"10.3389\/fmed.2022.1055178","volume":"9","author":"C Ruediger","year":"2022","unstructured":"Ruediger C, Ninan J, Dyer K, Lyne S, Tieu J, Black RJ, et al. Diagnosis of giant cell arteritis by temporal artery biopsy is associated with biopsy length. Front Med (Lausanne). 2022;9:1055178.","journal-title":"Front Med (Lausanne)"},{"key":"3254_CR23","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s00393-015-1674-2","volume":"75","author":"YH Lee","year":"2016","unstructured":"Lee YH, Choi SJ, Ji JD, Song GG. Diagnostic accuracy of 18F-FDG PET or PET\/CT for large vessel vasculitis: a meta-analysis. Z Rheumatol. 2016;75:924\u201331.","journal-title":"Z Rheumatol"},{"key":"3254_CR24","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s00259-011-1830-0","volume":"38","author":"FL Besson","year":"2011","unstructured":"Besson FL, Parienti JJ, Bienvenu B, Prior JO, Costo S, Bouvard G, et al. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764\u201372.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3254_CR25","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1097\/MD.0000000000000622","volume":"94","author":"M Soussan","year":"2015","unstructured":"Soussan M, Nicolas P, Schramm C, Katsahian S, Pop G, Fain O, Mekinian A. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore). 2015;94:e622.","journal-title":"Medicine (Baltimore)"},{"key":"3254_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12149-019-01358-5","volume":"33","author":"B Hay","year":"2019","unstructured":"Hay B, Mariano-Goulart D, Bourdon A, Benkiran M, Vauchot F, De Verbizier D, et al. Diagnostic performance of 18F-FDG PET-CT for large vessel involvement assessment in patients with suspected giant cell arteritis and negative temporal artery biopsy. Ann Nucl Med. 2019;33:512\u201320.","journal-title":"Ann Nucl Med"},{"key":"3254_CR27","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/art.42325","volume":"74","author":"C Ponte","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. 2022 American College of Rheumatology\/EULAR Classification Criteria for Giant Cell Arteritis. Arthritis Rheumatol. 2022;74:1881\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"3254_CR28","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3899\/jrheum.170138","volume":"44","author":"AH Clifford","year":"2017","unstructured":"Clifford AH, Murphy EM, Burrell SC, Bligh MP, MacDougall RF, Heathcote JG, et al. Positron emission tomography\/computerized tomography in newly diagnosed patients with giant cell arteritis who are taking glucocorticoids. J Rheumatol. 2017;44:1859\u201366.","journal-title":"J Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03254-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03254-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03254-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T05:01:41Z","timestamp":1704344501000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03254-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3254"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03254-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"31 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by our institutional ethics committee (Clinical Research Ethics Committee of Bellvitge University Hospital-IDIBELL). The local ethics committee has confirmed that the findings in this report were based on normal clinical practice and are therefore suitable for dissemination. Since our study was performed retrospectively, we were exempted by the ethics committee from obtaining informed consent. While informed consent was not obtained from the patients, their clinical records and information were pseudonymized prior to analysis. This study was conducted in accordance with the principles of the Declaration of Helsinki and the International Conference for Harmonization.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}